Use of adenosine receptor agonists in therapy
US7790698B2 · kind B2 · utility
1Cited by
15References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Sep 7, 2010 |
| Priority date | — |
| Expiry date | Mar 5, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the class of adenosines, represented by structural formula I, wherein R is C1-4 alkoxy, and X is H or OH, are useful in a method of preventing, treating, or ameliorating various conditions or disorders, e.g., inflammation, which comprises administering a compound of formula I to a subject in need of such prevention, treatment, or amelioration, for example, at a dosage which gives rise to a peak plasma concentration in the subject that is less than the EC50 value of the compound at adenosine receptors at nH 7.4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.